> AdDIT: Adolescent Type 1 Diabetes Cardio-Renal Interventional Trial
The AdDIT trial is a multicentre placebo controlled intervention of an ACE inhibitor and/or a statin to reduce the risk of early nephropathy and atherosclerosis in adolescence, a critical period for determining lifetime risk of complications.
> Predicting complications in childhood-onset Type 1 Diabetes (T1D) using retinal image analysis
We are examining whether identification of risk markers by retinal image analysis in adolescence will prevent diabetes vascular complications in later life, using a well-characterised cohort with childhood onset T1D.
> Delivering improved medication and health outcomes for pediatric patients in hospitals with eHealth systems
A partnership project with the Australian Institute of Health Innovation examining implementation of eHealth systems to improve paediatric healthcare services at The Children's Hospital at Westmead and elsewhere.
> CoRD: the Cord blood Reinfusion in Diabetes Study
Determining whether stem cells in cord blood (stored at the time of birth and reinfused upon signs of pre-diabetes) can prevent or delay development of Type 1 diabetes in high risk children.
> ENDIA: Environmental Determinants of Islet Autoimmunity
A nationwide observational study to identify environmental triggers of diabetes, studying children who have a parent or sibling with Type 1 diabetes. More information can be found on th ENDIA study website.
> The intermittent fast diet for obese adolescents
An early start to cardiovascular disease prevention through assessment of dietary intervention strategies, such as the 5:2 intermittent fast diet, in adolescents with obesity problems.